NASDAQ:CYRN - Cyren Stock Price, Forecast & News

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Cyren Ltd (NASDAQ:CYRN) announced its earnings results on Wednesday, November, 13th. The technology company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The technology company had revenue of $9.50 million for the quarter, compared to the consensus estimate of $9.80 million. Cyren had a negative return on equity of 68.95% and a negative net margin of 47.56%. View Cyren's Earnings History.

Cyren is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Cyren.

1 Wall Street analysts have issued 12 month price objectives for Cyren's stock. Their forecasts range from $3.00 to $3.00. On average, they expect Cyren's share price to reach $3.00 in the next year. This suggests a possible upside of 134.4% from the stock's current price. View Analyst Price Targets for Cyren.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyren in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cyren.

Press coverage about CYRN stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cyren earned a news impact score of 2.0 on InfoTrie's scale. They also gave press coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Cyren.

Cyren saw a decline in short interest in December. As of December 31st, there was short interest totalling 15,200 shares, a decline of 35.3% from the December 15th total of 23,500 shares. Based on an average daily trading volume, of 31,000 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.1% of the shares of the company are sold short. View Cyren's Current Options Chain.

Some companies that are related to Cyren include ChannelAdvisor (ECOM), DIRTT Environmental (DRTT), Red Violet (RDVT), eGain (EGAN), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), MAM Software Group (MAMS), Inspired Entertainment (INSE), SharpSpring (SHSP), Great Elm Capital Group (GEC), Aware (AWRE), Medical Transcription Billing (MTBC), ImageWare Systems (IWSY), Mobivity (MFON) and CLPS (CLPS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), Biocept (BIOC), AVEO Pharmaceuticals (AVEO), Corbus Pharmaceuticals (CRBP), Inpixon (INPX), MEI Pharma (MEIP), Onconova Therapeutics (ONTX) and Pacific Ethanol (PEIX).

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRN stock can currently be purchased for approximately $1.28.

Cyren has a market capitalization of $75.93 million and generates $35.90 million in revenue each year. The technology company earns $-19,410,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. Cyren employs 248 workers across the globe.View Additional Information About Cyren.

The official website for Cyren is http://www.cyren.com/.

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]